Product Name

  • Name

    FORSKOLIN

  • EINECS 266-410-9
  • CAS No. 66575-29-9
  • Article Data9
  • CAS DataBase
  • Density 1.23 g/cm3
  • Solubility Soluble in ethanol, dimethylsulfoxide and chloroform. Insolule in water.
  • Melting Point 282-232 °C
  • Formula C22H34O7
  • Boiling Point 519.9 °C at 760 mmHg
  • Molecular Weight 410.508
  • Flash Point 171.8 °C
  • Transport Information
  • Appearance Colorless crystalline solid
  • Safety 22-36/37
  • Risk Codes 21
  • Molecular Structure Molecular Structure of 66575-29-9 (FORSKOLIN)
  • Hazard Symbols HarmfulXn
  • Synonyms 1H-Naphtho[2,1-b]pyran-1-one,5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-,[3R-(3a,4ab,5b,6b,6aa,10a,10ab,10ba)]-;(-)-Forskolin;Coleonol;ForsLean;HL 362;NSC 357088;NSC 375489;
  • PSA 113.29000
  • LogP 1.51990

Synthetic route

acetic anhydride
108-24-7

acetic anhydride

7-deacetyl forskolin
64657-20-1

7-deacetyl forskolin

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
In pyridine at 0℃; for 18h;100%
With pyridine at 0 - 20℃; for 18h;100%
With pyridine at 0℃; for 20h;83%
(13R)-Spiroforskolin
220423-84-7

(13R)-Spiroforskolin

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
In methanol for 96h;
7-deacetyl forskolin
64657-20-1

7-deacetyl forskolin

acetyl chloride
75-36-5

acetyl chloride

A

(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-(acetyloxy)-3-ethenyldodecahydro-5,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one
64657-21-2

(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-(acetyloxy)-3-ethenyldodecahydro-5,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one

B

forskolin
66575-29-9

forskolin

C

1-acetyl-7-deacetylforskolin

1-acetyl-7-deacetylforskolin

Conditions
ConditionsYield
With diisopropylamine In toluene for 3h; Ambient temperature; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane for 3h; Ambient temperature; Yield given. Yields of byproduct given;
(1S,6S,12S,16S,2R)-14-hydroxy-4,4,7,9,13,17,17-heptamethyl-3,5,8-trioxa-9-vinyltetracyclo[11.4.0.0.2,607,12]heptadecan-11-one
898546-13-9

(1S,6S,12S,16S,2R)-14-hydroxy-4,4,7,9,13,17,17-heptamethyl-3,5,8-trioxa-9-vinyltetracyclo[11.4.0.0.2,607,12]heptadecan-11-one

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 100 percent / sodium / 2-methyl-propan-2-ol / 29 h / 30 °C
2: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
3: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
4: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
5: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
6: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(2S,7S,13S,14S,6R,9R)-14-hydroxy-4,4,7,9,13,17,17-heptamethyl-3,5,8-trioxa-9-vinyltetracyclo[11.4.0.02,607,12]heptadec-11-one
93108-68-0

(2S,7S,13S,14S,6R,9R)-14-hydroxy-4,4,7,9,13,17,17-heptamethyl-3,5,8-trioxa-9-vinyltetracyclo[11.4.0.02,607,12]heptadec-11-one

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
2: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
3: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
4: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(1S,6S,12S,16S,2R,11R)-14-methoxy-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.0.2,607,12]heptadec-14-en-11-ol
898546-12-8

(1S,6S,12S,16S,2R,11R)-14-methoxy-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.0.2,607,12]heptadec-14-en-11-ol

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 80 percent / pyridine; chromium oxide / CH2Cl2 / 24 h / 20 °C
2: 100 percent / sodium / 2-methyl-propan-2-ol / 29 h / 30 °C
3: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
4: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
5: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
6: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
7: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(1S,6S,11S,12S,2R)-14-methoxy-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.0.2,607,12]heptadec-14-en-11-ol
115155-11-8

(1S,6S,11S,12S,2R)-14-methoxy-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.0.2,607,12]heptadec-14-en-11-ol

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
2: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
3: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
4: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
5: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(1S,6S,11S,12S,2R,16R)-14-methoxy-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.02,607,12]heptadec-13-en-11-ol
115155-09-4

(1S,6S,11S,12S,2R,16R)-14-methoxy-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.02,607,12]heptadec-13-en-11-ol

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
2: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
3: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(6S,11S,16S,1R,2R,12R,13R)-14-methoxy-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.0.2,607,12]heptadec-14-en-11,13-diol
898546-14-0

(6S,11S,16S,1R,2R,12R,13R)-14-methoxy-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.0.2,607,12]heptadec-14-en-11,13-diol

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
2: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(1S,7S,9S,3R,5R,8R,14R)-14-acetyloxy-8,9-dihydroxy-1,5,7,11,11-pentamethyl-6-oxa-5-vinyltricyclo[8.4.0.02,7]tetradec-3-yl acetate
157201-96-2

(1S,7S,9S,3R,5R,8R,14R)-14-acetyloxy-8,9-dihydroxy-1,5,7,11,11-pentamethyl-6-oxa-5-vinyltricyclo[8.4.0.02,7]tetradec-3-yl acetate

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1: 93 percent / p-toluenesulfonic acid / 24 h / 50 °C
2: 96 percent / lithium aluminumhydride / diethyl ether / 2.5 h / 20 °C
3: 89 percent / pyridinium chlorochromate; sodium acetate / CH2Cl2 / 3 h / 20 °C
4: 54 percent / potassium hydride / tetrahydrofuran / 0.5 h / 0 °C
5: 80 percent / pyridine; chromium oxide / CH2Cl2 / 24 h / 20 °C
6: 100 percent / sodium / 2-methyl-propan-2-ol / 29 h / 30 °C
7: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
8: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
9: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
10: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
11: 100 percent / pyridine / 18 h / 0 °C
View Scheme
ptychantin A

ptychantin A

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1: 100 percent / potassium hydroxide / methanol / 13.5 h / 20 °C
2: 93 percent / p-toluenesulfonic acid / 24 h / 50 °C
3: 96 percent / lithium aluminumhydride / diethyl ether / 2.5 h / 20 °C
4: 89 percent / pyridinium chlorochromate; sodium acetate / CH2Cl2 / 3 h / 20 °C
5: 54 percent / potassium hydride / tetrahydrofuran / 0.5 h / 0 °C
6: 80 percent / pyridine; chromium oxide / CH2Cl2 / 24 h / 20 °C
7: 100 percent / sodium / 2-methyl-propan-2-ol / 29 h / 30 °C
8: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
9: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
10: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
11: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
12: 100 percent / pyridine / 18 h / 0 °C
View Scheme
ptychantin B

ptychantin B

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1: 89 percent / potassium hydroxide / methanol / 13.5 h / 20 °C
2: 93 percent / p-toluenesulfonic acid / 24 h / 50 °C
3: 96 percent / lithium aluminumhydride / diethyl ether / 2.5 h / 20 °C
4: 89 percent / pyridinium chlorochromate; sodium acetate / CH2Cl2 / 3 h / 20 °C
5: 54 percent / potassium hydride / tetrahydrofuran / 0.5 h / 0 °C
6: 80 percent / pyridine; chromium oxide / CH2Cl2 / 24 h / 20 °C
7: 100 percent / sodium / 2-methyl-propan-2-ol / 29 h / 30 °C
8: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
9: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
10: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
11: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
12: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(2S,7S,13S,6R,9R,14R)-14-hydroxy-4,4,7,9,13,17,17-heptamethyl-3,5,8-trioxa-9-vinyltetracyclo[11.4.0.02,6.07,12]heptadecan-11-one
537038-62-3

(2S,7S,13S,6R,9R,14R)-14-hydroxy-4,4,7,9,13,17,17-heptamethyl-3,5,8-trioxa-9-vinyltetracyclo[11.4.0.02,6.07,12]heptadecan-11-one

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 54 percent / potassium hydride / tetrahydrofuran / 0.5 h / 0 °C
2: 80 percent / pyridine; chromium oxide / CH2Cl2 / 24 h / 20 °C
3: 100 percent / sodium / 2-methyl-propan-2-ol / 29 h / 30 °C
4: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
5: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
6: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
7: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
8: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(1S,6S,12S,2R,11R,14R,16R)-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.02,6.07,12]heptadecane-11,14-diol
536742-35-5

(1S,6S,12S,2R,11R,14R,16R)-1,4,4,8,8,12,16-heptamethyl-3,5,17-trioxa-16-vinyltetracyclo[11.4.0.02,6.07,12]heptadecane-11,14-diol

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 89 percent / pyridinium chlorochromate; sodium acetate / CH2Cl2 / 3 h / 20 °C
2: 54 percent / potassium hydride / tetrahydrofuran / 0.5 h / 0 °C
3: 80 percent / pyridine; chromium oxide / CH2Cl2 / 24 h / 20 °C
4: 100 percent / sodium / 2-methyl-propan-2-ol / 29 h / 30 °C
5: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
6: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
7: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
8: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
9: 100 percent / pyridine / 18 h / 0 °C
View Scheme
(2S,7S,13S,6R,9R,11R,14R)-14-acetyloxy-4,4,7,9,13,17,17-heptamethyl-3,5,8-trioxa-9-vinyltetracyclo[11.4.0.02,6.07,12]heptadec-11-yl acetate
536742-34-4

(2S,7S,13S,6R,9R,11R,14R)-14-acetyloxy-4,4,7,9,13,17,17-heptamethyl-3,5,8-trioxa-9-vinyltetracyclo[11.4.0.02,6.07,12]heptadec-11-yl acetate

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: 96 percent / lithium aluminumhydride / diethyl ether / 2.5 h / 20 °C
2: 89 percent / pyridinium chlorochromate; sodium acetate / CH2Cl2 / 3 h / 20 °C
3: 54 percent / potassium hydride / tetrahydrofuran / 0.5 h / 0 °C
4: 80 percent / pyridine; chromium oxide / CH2Cl2 / 24 h / 20 °C
5: 100 percent / sodium / 2-methyl-propan-2-ol / 29 h / 30 °C
6: 100 percent / aqueous hydrochloric acid / tetrahydrofuran / 1 h / 20 °C
7: 96 percent / potassium hydride / tetrahydrofuran / 0.13 h / 20 °C
8: 61 percent / potassium carbonate; m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C
9: 59 percent / perchloric acid / tetrahydrofuran / 264 h / 20 °C
10: 100 percent / pyridine / 18 h / 0 °C
View Scheme
rac-5α<<(tert-Butyl)dimethylsilyl>oxy>-4β-ethinyl-1,4,4a,5,6,7,8,8aα-octahydro-4-hydroxy-3,4aα,8,8-tetramethylnaphthalin-1(4H)-on
123218-03-1, 123218-04-2

rac-5α<<(tert-Butyl)dimethylsilyl>oxy>-4β-ethinyl-1,4,4a,5,6,7,8,8aα-octahydro-4-hydroxy-3,4aα,8,8-tetramethylnaphthalin-1(4H)-on

A

C22H34O7

C22H34O7

B

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 15 steps
1.1: diisobutylaluminium hydride / tetrahydrofuran / 2 h / -78 °C
2.1: dmap / N,N-dimethyl-formamide / 13 h / 65 °C
3.1: pyridinium chlorochromate; sodium acetate / dichloromethane / 72 h / 30 °C / Molecular sieve
4.1: diisobutylaluminium hydride / tetrahydrofuran / 1 h / 0 °C
5.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
6.1: triethylamine / chloroform / 1 h / 23 °C
7.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
8.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
9.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
10.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
11.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
12.1: n-butyllithium / hexane / 0.5 h / 23 °C
12.2: 1.17 h / -78 - -30 °C
13.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
14.1: pyridine / 20 h / 0 °C
15.1: Chiralpak® AD-H / hexane; ethanol / Resolution of racemate
View Scheme
rac-5α<<(tert-Butyl)dimethylsilyl>oxy>-4β-ethinyl-1,4,4a,5,6,7,8,8aα-octahydro-4-hydroxy-3,4aα,8,8-tetramethylnaphthalin-1(4H)-on
123218-03-1, 123218-04-2

rac-5α<<(tert-Butyl)dimethylsilyl>oxy>-4β-ethinyl-1,4,4a,5,6,7,8,8aα-octahydro-4-hydroxy-3,4aα,8,8-tetramethylnaphthalin-1(4H)-on

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 17 steps
1.1: diisobutylaluminium hydride / tetrahydrofuran / 2 h / -78 °C
2.1: dmap / N,N-dimethyl-formamide / 13 h / 65 °C
3.1: pyridinium chlorochromate; sodium acetate / dichloromethane / 72 h / 30 °C / Molecular sieve
4.1: diisobutylaluminium hydride / tetrahydrofuran / 1 h / 0 °C
5.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
6.1: triethylamine / chloroform / 1 h / 23 °C
7.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
8.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
9.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
10.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
11.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
12.1: n-butyllithium / hexane / 0.5 h / 23 °C
12.2: 1.17 h / -78 - -30 °C
13.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
14.1: pyridine / 20 h / 0 °C
15.1: dmap; triethylamine / dichloromethane / 1 h / 23 °C
16.1: potassium carbonate / methanol; water / 6 h / 23 °C
17.1: pyridine / 20 h / 0 °C
View Scheme
C22H38O3Si

C22H38O3Si

A

C22H34O7

C22H34O7

B

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 14 steps
1.1: dmap / N,N-dimethyl-formamide / 13 h / 65 °C
2.1: pyridinium chlorochromate; sodium acetate / dichloromethane / 72 h / 30 °C / Molecular sieve
3.1: diisobutylaluminium hydride / tetrahydrofuran / 1 h / 0 °C
4.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
5.1: triethylamine / chloroform / 1 h / 23 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
7.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
8.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
9.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
10.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
11.1: n-butyllithium / hexane / 0.5 h / 23 °C
11.2: 1.17 h / -78 - -30 °C
12.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
13.1: pyridine / 20 h / 0 °C
14.1: Chiralpak® AD-H / hexane; ethanol / Resolution of racemate
View Scheme
C22H38O3Si

C22H38O3Si

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 16 steps
1.1: dmap / N,N-dimethyl-formamide / 13 h / 65 °C
2.1: pyridinium chlorochromate; sodium acetate / dichloromethane / 72 h / 30 °C / Molecular sieve
3.1: diisobutylaluminium hydride / tetrahydrofuran / 1 h / 0 °C
4.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
5.1: triethylamine / chloroform / 1 h / 23 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
7.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
8.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
9.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
10.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
11.1: n-butyllithium / hexane / 0.5 h / 23 °C
11.2: 1.17 h / -78 - -30 °C
12.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
13.1: pyridine / 20 h / 0 °C
14.1: dmap; triethylamine / dichloromethane / 1 h / 23 °C
15.1: potassium carbonate / methanol; water / 6 h / 23 °C
16.1: pyridine / 20 h / 0 °C
View Scheme
C29H42O4Si

C29H42O4Si

A

C22H34O7

C22H34O7

B

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 13 steps
1.1: pyridinium chlorochromate; sodium acetate / dichloromethane / 72 h / 30 °C / Molecular sieve
2.1: diisobutylaluminium hydride / tetrahydrofuran / 1 h / 0 °C
3.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
4.1: triethylamine / chloroform / 1 h / 23 °C
5.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
6.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
7.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
8.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
9.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
10.1: n-butyllithium / hexane / 0.5 h / 23 °C
10.2: 1.17 h / -78 - -30 °C
11.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
12.1: pyridine / 20 h / 0 °C
13.1: Chiralpak® AD-H / hexane; ethanol / Resolution of racemate
View Scheme
C29H42O4Si

C29H42O4Si

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 15 steps
1.1: pyridinium chlorochromate; sodium acetate / dichloromethane / 72 h / 30 °C / Molecular sieve
2.1: diisobutylaluminium hydride / tetrahydrofuran / 1 h / 0 °C
3.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
4.1: triethylamine / chloroform / 1 h / 23 °C
5.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
6.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
7.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
8.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
9.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
10.1: n-butyllithium / hexane / 0.5 h / 23 °C
10.2: 1.17 h / -78 - -30 °C
11.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
12.1: pyridine / 20 h / 0 °C
13.1: dmap; triethylamine / dichloromethane / 1 h / 23 °C
14.1: potassium carbonate / methanol; water / 6 h / 23 °C
15.1: pyridine / 20 h / 0 °C
View Scheme
C29H40O4Si

C29H40O4Si

A

C22H34O7

C22H34O7

B

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1.1: diisobutylaluminium hydride / tetrahydrofuran / 1 h / 0 °C
2.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
3.1: triethylamine / chloroform / 1 h / 23 °C
4.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
5.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
6.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
7.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
8.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
9.1: n-butyllithium / hexane / 0.5 h / 23 °C
9.2: 1.17 h / -78 - -30 °C
10.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
11.1: pyridine / 20 h / 0 °C
12.1: Chiralpak® AD-H / hexane; ethanol / Resolution of racemate
View Scheme
C29H40O4Si

C29H40O4Si

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 14 steps
1.1: diisobutylaluminium hydride / tetrahydrofuran / 1 h / 0 °C
2.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
3.1: triethylamine / chloroform / 1 h / 23 °C
4.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
5.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
6.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
7.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
8.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
9.1: n-butyllithium / hexane / 0.5 h / 23 °C
9.2: 1.17 h / -78 - -30 °C
10.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
11.1: pyridine / 20 h / 0 °C
12.1: dmap; triethylamine / dichloromethane / 1 h / 23 °C
13.1: potassium carbonate / methanol; water / 6 h / 23 °C
14.1: pyridine / 20 h / 0 °C
View Scheme
C22H38O3Si

C22H38O3Si

A

C22H34O7

C22H34O7

B

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
2.1: triethylamine / chloroform / 1 h / 23 °C
3.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
4.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
5.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
6.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
7.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
8.1: n-butyllithium / hexane / 0.5 h / 23 °C
8.2: 1.17 h / -78 - -30 °C
9.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
10.1: pyridine / 20 h / 0 °C
11.1: Chiralpak® AD-H / hexane; ethanol / Resolution of racemate
View Scheme
C22H38O3Si

C22H38O3Si

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 13 steps
1.1: pyridinium p-toluenesulfonate / dichloromethane / 0.25 h / 23 °C
2.1: triethylamine / chloroform / 1 h / 23 °C
3.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
4.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
5.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
6.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
7.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
8.1: n-butyllithium / hexane / 0.5 h / 23 °C
8.2: 1.17 h / -78 - -30 °C
9.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
10.1: pyridine / 20 h / 0 °C
11.1: dmap; triethylamine / dichloromethane / 1 h / 23 °C
12.1: potassium carbonate / methanol; water / 6 h / 23 °C
13.1: pyridine / 20 h / 0 °C
View Scheme
C25H42O3Si

C25H42O3Si

A

C22H34O7

C22H34O7

B

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: triethylamine / chloroform / 1 h / 23 °C
2.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
3.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
4.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
5.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
6.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
7.1: n-butyllithium / hexane / 0.5 h / 23 °C
7.2: 1.17 h / -78 - -30 °C
8.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
9.1: pyridine / 20 h / 0 °C
10.1: Chiralpak® AD-H / hexane; ethanol / Resolution of racemate
View Scheme
C25H42O3Si

C25H42O3Si

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1.1: triethylamine / chloroform / 1 h / 23 °C
2.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
3.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
4.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
5.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
6.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
7.1: n-butyllithium / hexane / 0.5 h / 23 °C
7.2: 1.17 h / -78 - -30 °C
8.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
9.1: pyridine / 20 h / 0 °C
10.1: dmap; triethylamine / dichloromethane / 1 h / 23 °C
11.1: potassium carbonate / methanol; water / 6 h / 23 °C
12.1: pyridine / 20 h / 0 °C
View Scheme
C27H45NO4Si

C27H45NO4Si

A

C22H34O7

C22H34O7

B

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
2.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
3.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
4.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
5.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
6.1: n-butyllithium / hexane / 0.5 h / 23 °C
6.2: 1.17 h / -78 - -30 °C
7.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
8.1: pyridine / 20 h / 0 °C
9.1: Chiralpak® AD-H / hexane; ethanol / Resolution of racemate
View Scheme
C27H45NO4Si

C27H45NO4Si

forskolin
66575-29-9

forskolin

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 7 h / 23 °C / Molecular sieve
2.1: citric acid; potassium osmate; 4-methylmorpholine N-oxide / water; tert-butyl alcohol / 120 h / 23 °C
3.1: toluene-4-sulfonic acid / acetone / 48 h / 23 °C
4.1: hydrogen / ethanol / 6 h / 23 °C / Schlenk technique
5.1: hydrogenchloride / toluene; 1,4-dioxane / 3 h / 23 °C
6.1: n-butyllithium / hexane / 0.5 h / 23 °C
6.2: 1.17 h / -78 - -30 °C
7.1: toluene-4-sulfonic acid / water; tetrahydrofuran / 288 h / 23 °C
8.1: pyridine / 20 h / 0 °C
9.1: dmap; triethylamine / dichloromethane / 1 h / 23 °C
10.1: potassium carbonate / methanol; water / 6 h / 23 °C
11.1: pyridine / 20 h / 0 °C
View Scheme
forskolin
66575-29-9

forskolin

1,1'-Thiocarbonyldiimidazole
6160-65-2

1,1'-Thiocarbonyldiimidazole

C23H32O7S

C23H32O7S

Conditions
ConditionsYield
With dmap In dichloromethane at 20℃; for 4h; Inert atmosphere;97%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

forskolin
66575-29-9

forskolin

1-(trimethylsilyl)forskolin
84010-19-5

1-(trimethylsilyl)forskolin

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 22℃; for 2h; Inert atmosphere;92%
With pyridine; 1,1,1,3,3,3-hexamethyl-disilazane at 80 - 85℃; for 2h;77%
p-methoxybenzyloxy acetic acid
88920-24-5

p-methoxybenzyloxy acetic acid

forskolin
66575-29-9

forskolin

7β-acetoxy-6β,9α-dihydroxy-8,13-epoxy-1α-<(4-methoxybenzyloxy)acetoxy>labd-14-en-11-one
120370-89-0

7β-acetoxy-6β,9α-dihydroxy-8,13-epoxy-1α-<(4-methoxybenzyloxy)acetoxy>labd-14-en-11-one

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In ethyl acetate for 3h; Ambient temperature;92%
forskolin
66575-29-9

forskolin

2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

C25H38O7
119603-26-8

C25H38O7

Conditions
ConditionsYield
With toluene-4-sulfonic acid In acetone at 0 - 20℃; for 6h; Inert atmosphere;92%
triethyl borane
97-94-9

triethyl borane

forskolin
66575-29-9

forskolin

ethyl iodoacetae
623-48-3

ethyl iodoacetae

C28H45BO9

C28H45BO9

Conditions
ConditionsYield
With 4-tert-Butylcatechol; sodium hydrogencarbonate In dichloromethane; benzene at 20℃; for 3h; Darkness;91%
forskolin
66575-29-9

forskolin

14,15-dihydroforskolin
64657-24-5

14,15-dihydroforskolin

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol at 20℃;90%
palladium-carbon In methanol
forskolin
66575-29-9

forskolin

1-deoxy-1-oxoforskolin
81873-10-1

1-deoxy-1-oxoforskolin

Conditions
ConditionsYield
With 4-methyl-morpholine; 6C13H13P*4CF3O3S(1-)*2Ru(2+); acetone at 65℃; for 3h; Inert atmosphere; Sealed tube;88%
With Collins oxidation agent In dichloromethane for 2.5h;1.2 g
forskolin
66575-29-9

forskolin

allyl alcohol
107-18-6

allyl alcohol

1,9-O-[(3-allyloxy)propylidene]forskolin

1,9-O-[(3-allyloxy)propylidene]forskolin

Conditions
ConditionsYield
With ammonium cerium (IV) nitrate In acetonitrile at 20℃; for 24h; Inert atmosphere; regioselective reaction;87%
phosgene
75-44-5

phosgene

forskolin
66575-29-9

forskolin

forskolin 1,9-carbonate
81826-81-5

forskolin 1,9-carbonate

Conditions
ConditionsYield
With pyridine In toluene at 0 - 20℃; for 4.5h;86%
With pyridine In toluene at 0℃; for 1h;1.22 g
4-[(dimethylamino)methyl]benzoic acid hydrochloride

4-[(dimethylamino)methyl]benzoic acid hydrochloride

forskolin
66575-29-9

forskolin

7β-acetoxy-6β,9α-dihydroxy-1α-(4-dimethylaminomethylbenzoyloxy)-8,13-epoxy-labd-14-en-11-one hydrochloride

7β-acetoxy-6β,9α-dihydroxy-1α-(4-dimethylaminomethylbenzoyloxy)-8,13-epoxy-labd-14-en-11-one hydrochloride

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide for 16h;82.3%
forskolin
66575-29-9

forskolin

7-deacetyl forskolin
64657-20-1

7-deacetyl forskolin

Conditions
ConditionsYield
With ethylenediamine In methanol for 0.0833333h; Microwave irradiation;80%
With sodium hydroxide In methanol; water
With potassium carbonate In methanol at 25℃; for 0.75h;
With water first-order plots of degradation in water and phosphate buffer (pH 6.0-8.0);
In methanol; potassium carbonate
forskolin
66575-29-9

forskolin

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

7β-acetoxy-1α-<(tert-butyldimethylsilyl)oxy>-6β,9α-dihydroxy-8,13-epoxylabd-14-en-11-one
105559-76-0

7β-acetoxy-1α-<(tert-butyldimethylsilyl)oxy>-6β,9α-dihydroxy-8,13-epoxylabd-14-en-11-one

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 70℃; for 22h;80%
forskolin
66575-29-9

forskolin

1-(prop-2-yn-1-yl)-1H-indole-3-carbaldehyde

1-(prop-2-yn-1-yl)-1H-indole-3-carbaldehyde

1,9-O-(N-propargyl-3-indolylidene)forskolin

1,9-O-(N-propargyl-3-indolylidene)forskolin

Conditions
ConditionsYield
With Amberlist-15 wet In 1,2-dichloro-ethane at 20℃; for 24h;75%
forskolin
66575-29-9

forskolin

acetone
67-64-1

acetone

C25H38O7
119603-26-8

C25H38O7

Conditions
ConditionsYield
With aluminium trichloride In diethyl ether for 0.3h; Ambient temperature;74%
forskolin
66575-29-9

forskolin

benzoyl chloride
98-88-4

benzoyl chloride

1-benzoylforskolin
84048-17-9

1-benzoylforskolin

Conditions
ConditionsYield
With pyridine Ambient temperature;72%
forskolin
66575-29-9

forskolin

acetyl chloride
75-36-5

acetyl chloride

Acetic acid (3S,4aR,5S,6S,6aS,10S,10aR,10bS)-5-acetoxy-3-ethyl-6,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-benzo[f]chromen-10-yl ester
84010-29-7

Acetic acid (3S,4aR,5S,6S,6aS,10S,10aR,10bS)-5-acetoxy-3-ethyl-6,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-benzo[f]chromen-10-yl ester

Conditions
ConditionsYield
With pyridine Ambient temperature;72%
triethyl borane
97-94-9

triethyl borane

((Iodomethyl)sulfonyl)benzene
65492-21-9

((Iodomethyl)sulfonyl)benzene

forskolin
66575-29-9

forskolin

C31H45BO9S

C31H45BO9S

Conditions
ConditionsYield
With 4-tert-Butylcatechol; sodium hydrogencarbonate In dichloromethane; benzene at 20℃; for 3h; Darkness;63%
pivaloyl chloride
3282-30-2

pivaloyl chloride

forskolin
66575-29-9

forskolin

7-deacetyl-1,7-dipivaloylforskolin
84010-28-6

7-deacetyl-1,7-dipivaloylforskolin

Conditions
ConditionsYield
With pyridine Ambient temperature;55%
forskolin
66575-29-9

forskolin

benzoyl chloride
98-88-4

benzoyl chloride

C34H40O8
84048-21-5

C34H40O8

Conditions
ConditionsYield
With pyridine Ambient temperature;55%
forskolin
66575-29-9

forskolin

forskolin-14,15-dibromide
84010-25-3

forskolin-14,15-dibromide

Conditions
ConditionsYield
With bromine In carbon disulfide at 0 - 20℃; for 2.75h;50%
forskolin
66575-29-9

forskolin

phenyl isocyanate
103-71-9

phenyl isocyanate

1-(anilinocarbonyl)forskolin
84048-18-0

1-(anilinocarbonyl)forskolin

Conditions
ConditionsYield
In toluene for 20h; Heating;48%
forskolin
66575-29-9

forskolin

(13R)-Spiroforskolin
220423-84-7

(13R)-Spiroforskolin

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In benzene at 0 - 5℃;45%
forskolin
66575-29-9

forskolin

benzoic acid
65-85-0

benzoic acid

1β-Benzoyloxy-1-deoxycoleonol
132620-05-4

1β-Benzoyloxy-1-deoxycoleonol

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran for 36h; Ambient temperature;45%
forskolin
66575-29-9

forskolin

A

7β-acetoxy-8,13-epoxy-6β-hydroxy-11-oxolabd-14-ene-1α,9α-diyl cyclo-α-phosphite
144426-70-0, 144539-48-0

7β-acetoxy-8,13-epoxy-6β-hydroxy-11-oxolabd-14-ene-1α,9α-diyl cyclo-α-phosphite

B

7β-acetoxy-8,13-epoxy-6β-hydroxy-11-oxolabd-14-ene-1α,9α-diyl cyclo-β-phosphite
144426-70-0, 144539-48-0

7β-acetoxy-8,13-epoxy-6β-hydroxy-11-oxolabd-14-ene-1α,9α-diyl cyclo-β-phosphite

Conditions
ConditionsYield
With pyridine; bis(trifluoroethyl)hydrogen phosphite for 16h; Ambient temperature;A 39%
B 13%
forskolin
66575-29-9

forskolin

propargyl bromide
106-96-7

propargyl bromide

A

1-O-propargyl-forskolin
1350721-63-9

1-O-propargyl-forskolin

B

1-O-propargyl-6-O-acetyl-7-deacetyl-forskolin
1350721-66-2

1-O-propargyl-6-O-acetyl-7-deacetyl-forskolin

Conditions
ConditionsYield
With potassium carbonate; sodium iodide In acetone at 20℃; Reflux;A 36%
B 35%
With potassium carbonate; potassium iodide In acetone for 24h; Reflux;A 1.8 g
B 1.7 g
forskolin
66575-29-9

forskolin

A

7β-acetoxy-8,13-epoxy-6β-hydroxy-11-oxolabd-14-ene-1α,9α-diyl cyclophospho-α-chloridate
144426-66-4, 144491-36-1

7β-acetoxy-8,13-epoxy-6β-hydroxy-11-oxolabd-14-ene-1α,9α-diyl cyclophospho-α-chloridate

B

7β-acetoxy-8,13-epoxy-6β-hydroxy-11-oxolabd-14-ene-1α,9α-diyl cyclophospho-β-chloridate
144426-66-4, 144491-36-1

7β-acetoxy-8,13-epoxy-6β-hydroxy-11-oxolabd-14-ene-1α,9α-diyl cyclophospho-β-chloridate

Conditions
ConditionsYield
With pyridine; triethylamine; trichlorophosphate In diethyl ether 1) -10 deg C, 1 h, 2) RT, 60 h; other substrate, various phosphorylating agents;A 33%
B 12%
With pyridine; triethylamine; trichlorophosphate In diethyl ether 1) -10 deg C, 1 h, 2) RT, 60 h;A 33%
B 12%
forskolin
66575-29-9

forskolin

3,5-dinitrobenoyl chloride
99-33-2

3,5-dinitrobenoyl chloride

6β-acetoxy-7β-(3,5-dinitro)benzoyloxy-8,13-epoxy-1α,9-dihydroxy-labd-14-en-11-one

6β-acetoxy-7β-(3,5-dinitro)benzoyloxy-8,13-epoxy-1α,9-dihydroxy-labd-14-en-11-one

Conditions
ConditionsYield
With pyridine at 20℃; for 1.5h;31%
forskolin
66575-29-9

forskolin

7β-acetoxy-8,13-epoxy-6β,9α-dihydroxy-11-oxolabd-14-en-1α-yl dihydrogen phosphate
144426-76-6

7β-acetoxy-8,13-epoxy-6β,9α-dihydroxy-11-oxolabd-14-en-1α-yl dihydrogen phosphate

Conditions
ConditionsYield
With dihydro-(1,2-dibromo-2-phenyl-1-ethyl)phosphonic acid; N-ethyl-N,N-diisopropylamine In dichloromethane for 48h; Ambient temperature;30%

Forskolin Chemical Properties

IUPAC Name: (3-Ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl) acetate
Systematic of 1H-Naphtho[2,1-b]pyran-1-one,5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-,(3R,4aR,5S,6S,6aS,10S,10aR,10bS)- (CAS NO.66575-29-9 ): 3R,4aR,5S,6S,6aS,10S,10aR,10bS)-Dodecahydro-5,6,10,10b-tetrahydroxy-3,4a,7,7,10a-pentamethyl-3-vinyl-1H-naphtho(2,1-b)pyran-1-one 5-acetate ; 1H-Naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3R-(3alpha,4abeta,5beta,6beta,6aalpha,10alpha,10abeta,10balpha))- ; 7-beta-Acetoxy-8,13-epoxy-1-alpha,6-beta,9-alpha-trihydroxylabd-14-en-11-one ; Boforsin ; Colforsinum [Latin] ; EINECS 266-410-9 ; Forskolin ; HL 362 ; L 75 1362B ; M 410 ; NSC 357088 ; NSC 375489 ; UNII-1F7A44V6OU
CAS NO: 66575-29-9
Classification Code: Adjuvants, Immunologic ; Anti-Asthmatic Agents ; Antiglaucoma agent ; Autonomic Agents ; Bronchodilator Agents ; Cardiotonic Agents ; Cardiovascular Agents ; Drug / Therapeutic Agent ; Immunologic Factors ; Natural Product ; Peripheral Nervous System Agents ; Protective Agents ; Respiratory System Agents ; Vasodilator Agents
Molecular Formula of 1H-Naphtho[2,1-b]pyran-1-one,5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-,(3R,4aR,5S,6S,6aS,10S,10aR,10bS)- (CAS NO.66575-29-9 ): C22H34O7
Molecular Weight: 410.5012
Molecular Structure:

Melting Point: 282-232 °C 
H bond acceptors: 7
H bond donors: 3
Freely Rotating Bonds: 6
Polar Surface Area: 80.29 Å2
Index of Refraction: 1.551
Molar Refractivity: 105.82 cm3
Molar Volume: 331.3 cm3
Surface Tension: 51.4 dyne/cm
Density of 1H-Naphtho[2,1-b]pyran-1-one,5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-,(3R,4aR,5S,6S,6aS,10S,10aR,10bS)- (CAS NO.66575-29-9 ): 1.23 g/cm3
Flash Point: 171.8 °C
Enthalpy of Vaporization: 91.23 kJ/mol
Boiling Point: 519.9 °C at 760 mmHg
Vapour Pressure: 5.56E-13 mmHg at 25°C

Forskolin Uses

 1H-Naphtho[2,1-b]pyran-1-one,5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-,(3R,4aR,5S,6S,6aS,10S,10aR,10bS)- (CAS NO.66575-29-9 ) is used as possessing vasodilating and cardiostimulatory properties.

Forskolin Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 68mg/kg (68mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) Journal of Ethnopharmacology. Vol. 3, Pg. 1, 1981.
mouse LD50 oral 3100mg/kg (3100mg/kg)   Medicinal Research Reviews. Vol. 3, Pg. 201, 1983.
rat LD50 intraperitoneal 92mg/kg (92mg/kg)   Journal of Medicinal Chemistry. Vol. 31, Pg. 1872, 1988.
rat LD50 oral 2550mg/kg (2550mg/kg)   Medicinal Research Reviews. Vol. 3, Pg. 201, 1983.

Forskolin Safety Profile

Hazard Codes: HarmfulXn
Risk Statements: 21 
R21: Harmful in contact with skin.
Safety Statements: 22-36/37 
S22: Do not breathe dust. 
S36/37: Wear suitable protective clothing and gloves.
WGK Germany :3
RTECS: QL6150000
F: 10-21

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View